DMAAU

Drugs Made In America Acquisition Corp. Units

10.53

USD

DMAAU Earnings Reports

Positive Surprise Ratio

No Data Available for DMAAU

Next Report

Date of Next Report

Mar 18, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Drugs Made In America Acquisition Corp. Units earnings per share and revenue

On Nov 17, 2025, DMAAU reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Drugs Made In America Acquisition Corp. Units's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Drugs Made In America Acquisition Corp. Units reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.

How did the market react to Drugs Made In America Acquisition Corp. Units's Q3 2025 earnings?

The stock price moved -- --, changed from -- before the earnings release to -- the day after.

When is Drugs Made In America Acquisition Corp. Units expected to report next?

The next earning report is scheduled for Mar 18, 2026.

What are the forecasts for Drugs Made In America Acquisition Corp. Units's next earnings report?

Based on -- analysts, Drugs Made In America Acquisition Corp. Units is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.